Propanc Biopharma, Inc. (PPCB)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 34.15 Thousand | 28.84 Thousand | 28.36 Thousand | 28.11 Thousand | 32.8 Thousand | 28.06 Thousand |
| Gross Profit | -34.15 Thousand | -28.84 Thousand | -28.36 Thousand | -28.11 Thousand | -32.8 Thousand | -28.06 Thousand |
| Operating Expenses | 1.5 Million | 1.77 Million | 1.99 Million | 1.81 Million | 3.49 Million | 2.61 Million |
| Selling, General and Administrative Expenses | 1.28 Million | 1.52 Million | 1.73 Million | 1.58 Million | 3.31 Million | 2.35 Million |
| Research and Development Expenses | 248.1 Thousand | 247.91 Thousand | 256.05 Thousand | 230.95 Thousand | 179.98 Thousand | 260.33 Thousand |
| Other Expenses | - | 1.49 Million | 1.7 Million | 1.55 Million | 57.63 Thousand | 2.32 Million |
| Cost and Expenses | 1.53 Million | 1.77 Million | 1.99 Million | 1.81 Million | 3.49 Million | 2.61 Million |
| Operating Income | -1.53 Million | -1.77 Million | -1.99 Million | -1.81 Million | -3.49 Million | -2.61 Million |
| Interest Expense | 665.78 Thousand | 532.82 Thousand | 568.79 Thousand | 449.45 Thousand | 1.74 Million | 1.31 Million |
| Income Tax Expense | -129.13 Thousand | -129.84 Thousand | -54.97 Thousand | -113.41 Thousand | -134.72 Thousand | -115.43 Thousand |
| Earnings before Tax | -1.94 Million | -2.79 Million | -2.71 Million | -2.13 Million | -4.87 Million | -5.87 Million |
| Net Income | -1.82 Million | -3.13 Million | -3.36 Million | -2.42 Million | -4.74 Million | -5.76 Million |
| Earnings Per Share Basic | -0.02 | -1.80 | -49.23 | -797.23 | -192.45 Thousand | -10.96 Million |
| Earnings Per Share Diluted | -0.02 | -1.80 | -49.23 | -797.23 | -192.45 Thousand | -10.96 Million |
| Weighted Average Shares Outstanding | 85.04 Million | 1.73 Million | 68.21 Thousand | 3032.61 | 24.63 | 0.52 |
| Weighted Average Shares Outstanding (Diluted) | 85.04 Million | 1.73 Million | 68.21 Thousand | 3032.61 | 24.63 | 0.52 |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -1.53 Million | -1.77 Million | -1.99 Million | -1.81 Million | -3.49 Million | -2.61 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 5764.00 | 4773.00 | 5857.00 | 7149.00 | 28.84 Thousand | 6597.00 |
| Gross Profit | -5764.00 | -4773.00 | -5857.00 | -7149.00 | -28.84 Thousand | -6597.00 |
| Operating Expenses | 259.89 Thousand | 416.09 Thousand | 438.06 Thousand | 410.07 Thousand | 1.77 Million | 209.6 Thousand |
| Selling, General and Administrative Expenses | 207.5 Thousand | 350.64 Thousand | 324.04 Thousand | 400.97 Thousand | - | 203.9 Thousand |
| Research and Development Expenses | 52.39 Thousand | 65.44 Thousand | 114.02 Thousand | 16.24 Thousand | - | 5696.00 |
| Other Expenses | - | 348.84 Thousand | 318.18 Thousand | 393.82 Thousand | 1.49 Million | 644.94 Thousand |
| Cost and Expenses | 259.89 Thousand | 420.86 Thousand | 438.06 Thousand | 417.21 Thousand | 1.77 Million | 209.6 Thousand |
| Operating Income | -259.89 Thousand | -420.87 Thousand | -438.06 Thousand | -417.21 Thousand | -1.77 Million | -209.6 Thousand |
| Interest Expense | 90 Thousand | 133.14 Thousand | 264.46 Thousand | -178.23 Thousand | 532.82 Thousand | 114.24 Thousand |
| Income Tax Expense | -237.00 | -275.00 | -128.62 Thousand | 142.57 Thousand | -129.84 Thousand | 1196.00 |
| Earnings before Tax | -358.81 Thousand | -526.97 Thousand | -713 Thousand | -350.86 Thousand | -2.79 Million | -746.84 Thousand |
| Net Income | -358.57 Thousand | -540 Thousand | -620 Thousand | -490 Thousand | -2.66 Million | -810 Thousand |
| Earnings Per Share Basic | -0.00 | -0.01 | -0.03 | -0.04 | - | -0.22 |
| Earnings Per Share Diluted | -0.00 | -0.01 | -0.03 | -0.04 | - | -0.22 |
| Weighted Average Shares Outstanding | 246.1 Million | 57.9 Million | 23.81 Million | 10.98 Million | 1.73 Million | 3.6 Million |
| Weighted Average Shares Outstanding (Diluted) | 246.04 Million | 59.63 Million | 23.81 Million | 10.98 Million | 1.73 Million | 3.6 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -254.13 Thousand | -416.1 Thousand | -432.19 Thousand | -417.21 Thousand | - | -204.03 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
300259
TRUE
MOHCY
FLUG-B
ABBV
IFAM